News
L’IDIBELL addresses in a NeuroDebat the current status of biomarkers of neurological pathologies
Motor neuron diseases, Alzheimer’s, headaches, and multiple sclerosis have been the four main blocks of NeuroDebat, organized by IDIBELL. The sessions were presented by Dr. Antoni Martínez Yélamos, group leader of IDIBELL and HUB, and moderated by professionals from the two centers and the Viladecans Hospital.
The Movember party in L’Hospitalet raises money for prostate cancer Research
The party, organized by the Debut restaurant, the Can Tisores hairdresser, Pessics de Ciencia, and IDIBELL had the participation of Álvaro Aytés, IDIBELL, and ICO researcher.
New guidelines for health care of transgender and gender diverse people
This is the eighth version of the Standards of Care for the Health of Transgender and Gender Diverse People, which aim to provide clinical guidance to health professionals to maximize their overall health, psychological well-being, and self-fulfillment.
Researchers define the molecular mechanism associated with juvenile Parkinson’s
A team from IDIBELL, UB, and the Neuroscience Institute observed that the lack of interaction between two neuronal adenosine receptors could be responsible for the alteration of brain circuits in early or juvenile Parkinson’s disease.
La Marató funds a project on obsessive-compulsive disorder
The project led by Dr. Maria del Pino Alonso, from IDIBELL and HUB, will receive almost 400,000 euros to search for new biomarkers predicting the long-term evolution of OCD.
Coffee could have a protective effect against endometrial cancer
An epidemiological study co-led by IDIBELL, the Catalan Institute of Oncology (ICO), and Harvard University (Boston, USA) observed that coffee consumption could have a protective effect against the risk of suffering endometrial cancer.
Organoids from the research group of Dr. Sandra Acosta exhibited at the CCCB exposition Cervells(s)
The Cervell(s) exhibition delves into this organ from different artistic, historical, and scientific perspectives, including the results of real projects such as the case of Dr. Sandra Acosta.
Patients with Idiopathic Pulmonary Fibrosis who follow a Mediterranean diet have fewer gastrointestinal adverse effects
Doctors Maria Molina and Vanesa Vicens Zygmunt presented the results of the MADIET clinical trial at the International Fibrosis Congress. The clinical trial was coordinated by the Pulmonology research group from IDIBELL and the Bellvitge University Hospital (HUB) with the participation of hospitals from six European countries.